AI Digital Pathology for Fibrosis in MASH and MASLD
Refining Pathology's Lens
We unveil unprecedented insights into fibrosis on tissue biopsies using our stain-free, AI-based digital pathology platform, enabling our partners to accelerate therapeutics.
Stain-free Imaging and AI Image Analysis
Augmenting Fibrosis Analysis
Our proprietary technology integrates label-free Second Harmonic Generation imaging and explainable AI to consistently visualize and quantify subtleties within biological tissues that conventional methods miss. By analyzing key morphological and architectural markers, we provide translatable data from preclinical studies to clinical trials.
Accelerating Therapeutic Development for Fibrosis
Mining Deep Data with Digital Pathology
Our imaging and analysis services accelerate advancements and regulatory approvals across the drug development and clinical diagnostic value chain.
Preclinical to Clinical Translatability
Enhancing Clinical Trial Efficiency and Success
Clinical Diagnostics Development
Transforming MASH Diagnostics with Next-generation Clinical Testing Solutions
"When benchmarked against reference fibrosis stages from expert pathologists’ consensus, HistoIndex's qFibrosis® aligns closely, and demonstrates greater consistency than traditional histology. This level of reproducibility is essential in clinical practice and represents an important step toward replacing subjective scoring with reliable, quantitative metrics."
Dr. Mazen Noureddin, MD, MHSc
Professor of Medicine, Transplant Hepatologist at Houston Methodist Hospital and a Co-Chairman of the Board Summit and Pinnacle Clinical Research
Who We Partner With
Industry
Academy
